In addition, these BRAF/MEKi-resistant cell lines displayed altered patterns of released immunomodulatory factors associated with pro-inflammatory and immunosuppressive functions, potentially contributing to tumor growth (28). The gene discussed is BRAF; the disease is neoplasm.